![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig2_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![PDF] Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. | Semantic Scholar PDF] Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/20f645769c6a873e8d78e0711d954ee16e2bc4bb/4-Figure1-1.png)
PDF] Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. | Semantic Scholar
![Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor | PNAS Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor | PNAS](https://www.pnas.org/cms/10.1073/pnas.1114420108/asset/ae923bac-77bb-430d-8659-f99cebe68579/assets/graphic/pnas.1114420108fig02.jpeg)
Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor | PNAS
![Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation | Nature Reviews Endocrinology Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41574-020-0349-5/MediaObjects/41574_2020_349_Fig1_HTML.png)
Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation | Nature Reviews Endocrinology
![Glucocorticoids and the innate immune system: Crosstalk with the Toll-like receptor signaling network - ScienceDirect Glucocorticoids and the innate immune system: Crosstalk with the Toll-like receptor signaling network - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0303720707001839-gr1.jpg)